Summary:
- This article discusses the latest developments in cancer therapies presented by Kura Oncology at the European Society for Medical Oncology (ESMO) Congress 2025.
- Kura Oncology is a clinical-stage biopharmaceutical company focused on the development of novel cancer treatments, including targeted therapies and immunotherapies.
- The article highlights the promising results of Kura's pipeline of cancer therapies, which have shown potential in treating various types of cancer, such as solid tumors and hematological malignancies.